| Target Price | $73.44 |
| Price | $59.53 |
| Potential |
23.37%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Moelis & Co 2027 .
The average Moelis & Co target price is $73.44.
This is
23.37%
register free of charge
$90.30
51.69%
register free of charge
$60.60
1.80%
register free of charge
|
|
| A rating was issued by 19 analysts: 10 Analysts recommend Moelis & Co to buy, 7 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Moelis & Co stock has an average upside potential 2027 of
23.37%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.52 | 1.80 |
| 26.98% | 18.54% | |
| EBITDA Margin | 18.91% | 21.85% |
| 23.20% | 15.52% | |
| Net Margin | 15.36% | 14.07% |
| 34.93% | 8.42% |
12 Analysts have issued a sales forecast Moelis & Co 2026 . The average Moelis & Co sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Moelis & Co EBITDA forecast 2026. The average Moelis & Co EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
14 Moelis & Co Analysts have issued a net profit forecast 2026. The average Moelis & Co net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 2.94 | 3.23 |
| 65.17% | 9.86% | |
| P/E | 18.25 | |
| EV/Sales | 2.55 |
14 Analysts have issued a Moelis & Co forecast for earnings per share. The average Moelis & Co EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| Keefe, Bruyette & Woods |
Locked
➜
Locked
|
Locked | Jul 10 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Jul 08 2026 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Apr 09 2026 |
| Keefe, Bruyette & Woods |
Locked
➜
Locked
|
Locked | Apr 08 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Apr 08 2026 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Apr 01 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jul 30 2026 |
|
Locked
Keefe, Bruyette & Woods:
Locked
➜
Locked
|
Jul 10 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Jul 08 2026 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Apr 09 2026 |
|
Locked
Keefe, Bruyette & Woods:
Locked
➜
Locked
|
Apr 08 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Apr 08 2026 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Apr 01 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


